Quick Answer
Microbot Medical Inc. reported Research And Development Expense of $6.28 million for the year ending 2025.
- Microbot Medical Inc. showed a decrease of -5.2% in Research And Development Expense from 2024 to 2025.
- This data is from Microbot Medical Inc.'s annual report (Form 10-K), filed with the SEC on March 26, 2026.
- XBRL data for this metric is available from 2009 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2015: $7.72 million | Q1 2016: -$219.0 thousand | Q2 2016: -$44.0 thousand | Q3 2016: -$340.0 thousand | Q1 2017: $184.0 thousand | Q2 2017: $377.0 thousand | Q3 2017: $339.0 thousand | Q1 2018: $496.0 thousand | Q2 2018: $747.0 thousand | Q3 2018: $623.0 thousand | Q1 2019: $587.0 thousand | Q2 2019: $741.0 thousand | Q3 2019: $843.0 thousand | Q1 2020: $691.0 thousand | Q2 2020: $669.0 thousand | Q3 2020: $1.04 million | Q1 2021: $1.12 million | Q2 2021: $1.39 million | Q3 2021: $1.39 million | Q1 2022: $1.71 million | Q2 2022: $2.19 million | Q3 2022: $1.95 million | Q1 2023: $1.62 million | Q2 2023: $1.37 million | Q3 2023: $1.61 million | Q1 2024: $1.17 million | Q2 2024: $1.42 million | Q3 2024: $2.06 million | Q1 2025: $1.46 million | Q2 2025: $2.11 million | Q3 2025: $1.17 million.
- Over the full 18 years of available data (2009 to 2025), Microbot Medical Inc.'s Research And Development Expense has declined by 68.5%.
- Historical annual values: Fiscal year 2025: $6.28 million | Fiscal year 2024: $6.63 million | Fiscal year 2023: $5.72 million | Fiscal year 2022: $7.74 million | Fiscal year 2021: $6.15 million | Fiscal year 2020: $3.40 million | Fiscal year 2019: $3.05 million | Fiscal year 2018: $2.52 million | Fiscal year 2017: $1.10 million | Fiscal year 2016: -$901.0 thousand | Fiscal year 2015: -$823.0 thousand | Fiscal year 2014: $21.50 million | Fiscal year 2014: $21.50 million | Fiscal year 2013: $19.37 million | Fiscal year 2012: $14.68 million | Fiscal year 2011: $19.94 million | Fiscal year 2010: $21.02 million | Fiscal year 2009: $19.93 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: